BFM
CNST

Boothbay Fund Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Boothbay Fund Management’s Portfolio CNST Stock Details CNST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-56,250
Closed -$1.9M – 2422
2021
Q2 		$1.9M Buy
+56,250
New +$1.43M 0.06% 403

Boothbay Fund Management's CNST Position: Q3 2021 in Review

Boothbay Fund Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 56,250 shares — an estimated $1.9M sold.

Boothbay Fund Management first reported a position in CNST in Q2 2021 and held it in 1 quarter. The position peaked at $1.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

  • Boothbay Fund Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 56,250 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.9M.
  • Boothbay Fund Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Boothbay Fund Management's Constellation Pharmaceuticals, Inc. position peaked at $1.9M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.